305 related articles for article (PubMed ID: 27256204)
21. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.
Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K
Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342
[TBL] [Abstract][Full Text] [Related]
22. Pathological outcomes and biochemical progression in men with T1c prostate cancer undergoing radical prostatectomy with prostate specific antigen 2.6 to 4.0 vs 4.1 to 6.0 ng/ml.
Makarov DV; Humphreys EB; Mangold LA; Walsh PC; Partin AW; Epstein JI; Freedland SJ
J Urol; 2006 Aug; 176(2):554-8. PubMed ID: 16813888
[TBL] [Abstract][Full Text] [Related]
23. Delayed radical prostatectomy after a period of active surveillance is not associated with the use of secondary treatments compared with immediate prostatectomy.
Arcot R; Cher ML; Qi J; Linsell SM; Dunn RL; George AK; Montie JE; Ginsburg KB;
Prostate; 2022 Feb; 82(3):323-329. PubMed ID: 34855239
[TBL] [Abstract][Full Text] [Related]
24. Is active surveillance a safe alternative in the management of localized prostate cancer? Pathological features of radical prostatectomy specimens in potential candidates for active surveillance.
Norman Z; Militza P; Andres F; Daniela F; Alejandro M; Catherine S; Juan F
Int Braz J Urol; 2014; 40(2):154-9. PubMed ID: 24856482
[TBL] [Abstract][Full Text] [Related]
25. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
Womble PR; Montie JE; Ye Z; Linsell SM; Lane BR; Miller DC;
Eur Urol; 2015 Jan; 67(1):44-50. PubMed ID: 25159890
[TBL] [Abstract][Full Text] [Related]
26. Population-Based Assessment of Determining Treatments for Prostate Cancer.
Chamie K; Williams SB; Hu JC
JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
[TBL] [Abstract][Full Text] [Related]
27. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
28. Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes?
van den Bergh RC; Steyerberg EW; Khatami A; Aus G; Pihl CG; Wolters T; van Leeuwen PJ; Roobol MJ; Schröder FH; Hugosson J;
Cancer; 2010 Mar; 116(5):1281-90. PubMed ID: 20066716
[TBL] [Abstract][Full Text] [Related]
29. Molecular Analysis of Low Grade Prostate Cancer Using a Genomic Classifier of Metastatic Potential.
Klein EA; Santiago-Jiménez M; Yousefi K; Robbins BA; Schaeffer EM; Trock BJ; Tosoian J; Haddad Z; Ra S; Karnes RJ; Jenkins RB; Cheville JC; Den RB; Dicker AP; Davicioni E; Freedland SJ; Ross AE
J Urol; 2017 Jan; 197(1):122-128. PubMed ID: 27569435
[TBL] [Abstract][Full Text] [Related]
30. Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications.
Han M; Pound CR; Potter SR; Partin AW; Epstein JI; Walsh PC
J Urol; 2001 Mar; 165(3):864-6. PubMed ID: 11176487
[TBL] [Abstract][Full Text] [Related]
31. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
32. Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup.
Moschini M; Sharma V; Zattoni F; Boorjian SA; Frank I; Gettman MT; Thompson RH; Tollefson MK; Kwon ED; Karnes RJ
J Urol; 2016 Jun; 195(6):1773-8. PubMed ID: 26723866
[TBL] [Abstract][Full Text] [Related]
33. Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer.
Freedland SJ; Kane CJ; Amling CL; Aronson WJ; Presti JC; Terris MK;
J Urol; 2006 Apr; 175(4):1298-302; discussion 1302-3. PubMed ID: 16515984
[TBL] [Abstract][Full Text] [Related]
34. Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen Testing.
Overholser S; Nielsen M; Torkko K; Cwilka D; Weaver B; Shi X; Leach RJ; Hernandez J; Huang T; Thompson IM; Thompson IM
J Urol; 2015 Sep; 194(3):680-4. PubMed ID: 25636657
[TBL] [Abstract][Full Text] [Related]
35. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
[TBL] [Abstract][Full Text] [Related]
36. Adverse Pathologic Features at Radical Prostatectomy: Effect of Preoperative Risk on Oncologic Outcomes.
Imnadze M; Sjoberg DD; Vickers AJ
Eur Urol; 2016 Jan; 69(1):143-8. PubMed ID: 25913389
[TBL] [Abstract][Full Text] [Related]
37. Low Use of Immediate and Delayed Postoperative Radiation for Prostate Cancer with Adverse Pathological Features.
Maurice MJ; Zhu H; Abouassaly R
J Urol; 2015 Oct; 194(4):972-6. PubMed ID: 25858420
[TBL] [Abstract][Full Text] [Related]
38. Outcome of primary versus deferred radical prostatectomy in the National Prostate Cancer Register of Sweden Follow-Up Study.
Holmström B; Holmberg E; Egevad L; Adolfsson J; Johansson JE; Hugosson J; Stattin P;
J Urol; 2010 Oct; 184(4):1322-7. PubMed ID: 20723940
[TBL] [Abstract][Full Text] [Related]
39. Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.
Luckenbaugh AN; Auffenberg GB; Hawken SR; Dhir A; Linsell S; Kaul S; Miller DC;
J Urol; 2017 Mar; 197(3 Pt 1):621-626. PubMed ID: 27663459
[TBL] [Abstract][Full Text] [Related]
40. Prostatectomy pathology findings in an active surveillance population.
Ramirez-Backhaus M; Iborra I; Gomez-Ferrer A; Rubio-Briones J
Arch Esp Urol; 2014 Jun; 67(5):431-9. PubMed ID: 24914842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
